Preliminary evidence for normalization of risk taking by modafinil in chronic cocaine users

Addictive Behaviors

Volumn 39, Issue 6, 2014, Pages 1057-1061

  Canavan, Sofija V ^a,b   Forselius, Erica L ^a   Bessette, Andrew J ^a   Morgan, Peter T ^a  

^a YALE UNIVERSITY   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Balloon analogue risk task; Cocaine dependence; Cognition; Modafinil; Risk taking

Indexed keywords

ALCOHOL; COCAINE; MODAFINIL; NICOTINE; PLACEBO; BENZHYDRYL DERIVATIVE; WAKEFULNESS PROMOTING AGENT;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BALLOON ANALOGUE RISK TASK; CLINICAL ARTICLE; COCAINE DEPENDENCE; COGNITIVE DEFECT; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HIGH RISK BEHAVIOR; HUMAN; INTELLIGENCE QUOTIENT; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; RESPONSE TIME; SUBSTANCE USE; TREATMENT OUTCOME; CHRONIC DISEASE; COCAINE-RELATED DISORDERS; COGNITION; COHORT ANALYSIS; DRUG EFFECTS; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL; TASK PERFORMANCE;

ADULT; BENZHYDRYL COMPOUNDS; CHRONIC DISEASE; COCAINE-RELATED DISORDERS; COGNITION; COHORT STUDIES; FEMALE; HUMANS; MALE; RISK-TAKING; TASK PERFORMANCE AND ANALYSIS; WAKEFULNESS-PROMOTING AGENTS;

EID: 84897573688     PISSN: 03064603     EISSN: 18736327     Source Type: Journal    
DOI: 10.1016/j.addbeh.2014.02.015     Document Type: Article

References (47)

1. Aharonovich E., Amrhein P.C., Bisaga A., Nunes E.V., Hasin D.S. Cognition, commitment language, and behavioral change among cocaine-dependent patients. Psychology of Addictive Behaviors 2008, 22(4):557-562.
2. Aharonovich E., Hasin D.S., Brooks A.C., Liu X., Bisaga A., Nunes E.V. Cognitive deficits predict low treatment retention in cocaine dependent patients. Drug and Alcohol Dependence 2006, 81(3):313-322. (Epub 2005 Sep 19).
3. Aklin W.M., Lejuez C.W., Zvolensky M.J., Kahler C.W., Gwadz M. Evaluation of behavioral measures of risk taking propensity with inner city adolescents. Behaviour Research and Therapy 2005, 43(2):215-228.
4. Anderson A.L., Reid M.S., Li S.H., Holmes T., Shemanski L., Slee A., et al. Modafinil for the treatment of cocaine dependence. Drug and Alcohol Dependence 2009, 104(1-2):133-139.
5. Beveridge T.J., Gill K.E., Hanlon C.A., Porrino L.J. Parallel studies of cocaine-related neural and cognitive impairment in humans and monkeys. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences 2008, 363(1507):3257-3266.
6. Bishara A.J., Pleskac T.J., Fridberg D.J., Yechiam E., Lucas J., Busemeyer J.R., et al. Similar processes despite divergent behavior in two commonly used measures of risky decision making. Journal of Behavioral Decision Making 2009, 22(4):435-454.
7. Bolla K.I., Cadet J.L., London E.D. The neuropsychiatry of chronic cocaine abuse. Journal of Neuropsychiatry and Clinical Neurosciences 1998, 10(3):280-289.
8. Bornovalova M.A., Daughters S.B., Hernandez G.D., Richards J.B., Lejuez C.W. Differences in impulsivity and risk-taking propensity between primary users of crack cocaine and primary users of heroin in a residential substance-use program. Experimental and Clinical Psychopharmacology 2005, 13(4):311-318.
9. Courtney K.E., Arellano R., Barkley-Levenson E., Gálvan A., Poldrack R.A., Mackillop J., et al. The relationship between measures of impulsivity and alcohol misuse: An integrative structural equation modeling approach. Alcoholism, Clinical and Experimental Research 2012, 36(6):923-931.
10. Dackis C.A., Kampman K.M., Lynch K.G., Pettinati H.M., O'Brien C.P. A double-blind, placebo-controlled trial of modafinil for cocaine dependence. Neuropsychopharmacology 2005, 30:205-211.
11. Dackis C.A., Kampman K.M., Lynch K.G., Plebani J.G., Pettinati H.M., Sparkman T., et al. A double-blind, placebo-controlled trial of modafinil for cocaine dependence. Journal of Substance Abuse Treatment 2012, 43:303-312.
12. Dean A.C., Sugar C.A., Hellemann G., London E.D. Is all risk bad? Young adult cigarette smokers fail to take adaptive risk in a laboratory decision-making test. Psychopharmacology 2011, 215(4):801-811.
13. Ersche K.D., Turton A.J., Chamberlain S.R., Müller U., Bullmore E.T., Robbins T.W. Cognitive dysfunction and anxious-impulsive personality traits are endophenotypes for drug dependence. The American Journal of Psychiatry 2012, 926-36.
14. Fernie G., Cole J.C., Goudie A.J., Field M. Risk-taking but not response inhibition or delay discounting predict alcohol consumption in social drinkers. Drug and Alcohol Dependence 2010, 112(1-2):54-61.
15. Gonzalez R., Schuster R.M., Mermelstein R.J., Vassileva J., Martin E.M., Diviak K.R. Performance of young adult cannabis users on neurocognitive measures of impulsive behavior and their relationship to symptoms of cannabis use disorders. Journal of Clinical and Experimental Neuropsychology 2012, 34(9):962-976.
16. Hart C.L., Haney M., Vosburg S.K., Rubin E., Foltin R.W. Smoked cocaine self-administration is decreased by modafinil. Neuropsychopharmacology 2008, 33(4):761-768.
17. Hopko D.R., Lejuez C.W., Daughters S.B., Aklin W.M., Osborne A., Simmons B.L., et al. Construct validity of the Balloon Analogue Risk Task (BART): Relationship with MDMA use by inner-city drug users in residential treatment. Journal of Psychopathology and Behavioral Assessment 2006, 28:95-101.
18. Jovanovski D., Erb S., Zakzanis K.K. Neurocognitive deficits in cocaine users: A quantitative review of the evidence. Journal of Clinical and Experimental Neuropsychology 2005, 27(2):189-204.
19. Kalechstein A.D., Mahoney J.J., Yoon J.H., Bennett R., De la Garza R. Modafinil, but not escitalopram, improves working memory and sustained attention in long-term, high-dose cocaine users. Neuropharmacology 2013, 64:472-478.
20. Killgore W.D., Grugle N.L., Killgore D.B., Leavitt B.P., Watlington G.I., McNair S., et al. Restoration of risk-propensity during sleep deprivation: Caffeine, dextroamphetamine, and modafinil. Aviation, Space, and Environmental Medicine 2008, 79(9):867-874.
21. Lee T.M., Guo L.G., Shi H.Z., Li Y.Z., Luo Y.J., Sung C.Y., et al. Neural correlates of traditional Chinese medicine induced advantageous risk-taking decision making. Brain and Cognition 2009, 71(3):354-361.
22. Lejuez C.W., Aklin W., Daughters S., Zvolensky M., Kahler C., Gwadz M. Reliability and validity of the youth version of the Balloon Analogue Risk Task (BART-Y) in the assessment of risk-taking behavior among inner-city adolescents. Journal of Clinical Child and Adolescent Psychology 2007, 36(1):106-111.
23. Lejuez C.W., Aklin W.M., Jones H.A., Richards J.B., Strong D.R., Kahler C.W., et al. The Balloon Analogue Risk Task (BART) differentiates smokers and nonsmokers. Experimental and Clinical Psychopharmacology 2003, 11(1):26-33.
24. Lejuez C.W., Read J.P., Kahler C.W., Richards J.B., Ramsey S.E., Stuart G.L., et al. Evaluation of a behavioral measure of risk taking: The Balloon Analogue Risk Task (BART). Journal of Experimental Psychology. Applied 2002, 8(2):75-84.
25. Lejuez C.W., Simmons B.L., Aklin W.M., Daughters S.B., Dvir S. Risk-taking propensity and risky sexual behavior of individuals in residential substance use treatment. Addictive Behaviors 2004, 29(8):1643-1647.
26. Lesieur H.R., Blume S.B. The South Oaks Gambling Screen (SOGS): A new instrument for the identification of pathological gamblers. The American Journal of Psychiatry 1987, 144(9):1184-1188.
27. Mariani J.J., Levin F.R. Psychostimulant treatment of cocaine dependence. The Psychiatric Clinics of North America 2012, 35(2):425-439. (2012 Jun).
28. Mata R., Hau R., Papassotiropoulos A., Hertwig R. DAT1 polymorphism is associated with risk taking in the Balloon Analogue Risk Task (BART). PLoS One 2012, 7(6).
29. McLellan A.T., Kushner H., Metzger D., Peters R., Smith I., Grissom G., et al. The fifth edition of the addiction severity index. Journal of Substance Abuse Treatment 1992, 9(3):199-213.
30. McLellan A.T., Luborsky L., Woody G.E., O'Brien C.P. An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. The Journal of Nervous and Mental Disease 1980, 168(1):26-33.
31. Miller W.R., Del Boca F.K. Measurement of drinking behavior using the Form 90 family of instruments. Journal of Studies on Alcohol. Supplement 1994, 12:112-118.
32. Minzenberg M.J., Carter C.S. Modafinil: A review of neurochemical actions and effects on cognition. Neuropsychopharmacology 2008, 33(7):1477-1502.
33. Morgan P.T., Malison R.T. Cocaine and sleep: Early abstinence. ScientificWorldJournal 2007, 7:223-230.
34. Morgan P.T., Pace-Schott E., Pittman B., Stickgold R., Malison R.T. Normalizing effects of modafinil on sleep in chronic cocaine users. The American Journal of Psychiatry 2010, 167(3):331-340.
35. Morgan P.T., Pace-Schott E.F., Sahul Z.H., Coric V., Stickgold R., Malison R.T. Sleep, sleep-dependent procedural learning and vigilance in chronic cocaine users: Evidence for occult insomnia. Drug and Alcohol Dependence 2006, 82(3):238-249.
36. Morgan P.T., Pace-Schott E.F., Sahul Z.H., Coric V., Stickgold R., Malison R.T. Sleep architecture, cocaine and visual learning. Addiction 2008, 103(8):1344-1352.
37. Müller U., Rowe J.B., Rittman T., Lewis C., Robbins T.W., Sahakian B.J. Effects of modafinil on non-verbal cognition, task enjoyment and creative thinking in healthy volunteers. Neuropharmacology 2013, 64:490-495.
38. Pleskac T.J., Wallsten T.S., Wang P., Lejuez C.W. Development of an automatic response mode to improve the clinical utility of sequential risk-taking tasks. Experimental and Clinical Psychopharmacology 2008, 16(6):555-564.
39. Ryan K.K., Mackillop J., Carpenter M.J. The relationship between impulsivity, risk-taking propensity and nicotine dependence among older adolescent smokers. Addictive Behaviors 2013, 38(1):1431-1434.
40. Shipley W.C. A self-administering scale for measuring intellectual impairment and deterioration. The Journal of Psychology 1940, 9:371-377.
41. Sobell L.C., Sobell M.B. Convergent validity: An approach to increasing confidence in treatment outcome conclusions with alcohol and drug abusers. Evaluation alcohol and drug abuse treatment effectiveness: Recent advances 1980, Pergamon Press, Almsford, NY. L.C. Sobell, M.B. Sobell, E. Ward (Eds.).
42. Sofuoglu M., DeVito E.E., Waters A.J., Carroll K.M. Cognitive enhancement as a treatment for drug addictions. Neuropsychopharmacology 2013, 64:452-463.
43. Tull M.T., Trotman A., Duplinsky M.S., Reynolds E.K., Daughters S.B., Potenza M.N., et al. The effect of PTSD on risk-taking propensity among crack/cocaine users in residential substance abuse treatment. Depression and Anxiety 2009, 26(12):1158-1164.
44. Vigil-Colet A. Impulsivity and decision making in the balloon analogue risk-tasking task. Personality and Individual Differences 2007, 43(1):37-45.
45. Volkow N.D., Fowler J.S., Wang G.J., Baler R., Telang F.J. Imaging dopamine's role in drug abuse and addiction. Neuropharmacology 2009, 56(Suppl. 1):3-8.
46. Volkow N.D., Tomasi D., Wang G.J., Telang F., Fowler J.S., Logan J., et al. Evidence that sleep deprivation downregulates dopamine D2R in ventral striatum in the human brain. Journal of Neuroscience 2012, 32(19):6711-6717.
47. Zachary R.A. Shipley Institute of Living Scale: Revised Manual 1986, Western Psychological Services, Los Angeles.